Log in

NASDAQ:GNCAGenocea Biosciences News Headlines

$3.09
-0.03 (-0.96 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.96
Now: $3.09
$3.15
50-Day Range
$1.81
MA: $2.66
$5.53
52-Week Range
$1.10
Now: $3.09
$5.75
Volume644,051 shs
Average Volume2.56 million shs
Market Capitalization$92.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Headlines

Genocea Biosciences (NASDAQ GNCA) News Headlines

Source:
DateHeadline
Genocea Biosciences Inc (NASDAQ:GNCA) Short Interest Up 25.8% in JulyGenocea Biosciences Inc (NASDAQ:GNCA) Short Interest Up 25.8% in July
americanbankingnews.com - August 6 at 12:11 AM
-$0.24 EPS Expected for Genocea Biosciences Inc (NASDAQ:GNCA) This Quarter-$0.24 EPS Expected for Genocea Biosciences Inc (NASDAQ:GNCA) This Quarter
americanbankingnews.com - August 5 at 4:16 AM
Genocea Biosciences (NASDAQ:GNCA) Stock Price Down 1.1%Genocea Biosciences (NASDAQ:GNCA) Stock Price Down 1.1%
americanbankingnews.com - August 3 at 3:51 PM
Genocea Biosciences Inc (NASDAQ:GNCA) Sees Large Growth in Short InterestGenocea Biosciences Inc (NASDAQ:GNCA) Sees Large Growth in Short Interest
www.americanbankingnews.com - August 1 at 1:06 AM
Genocea under pressure on underwhelming neoantigen vaccine dataGenocea under pressure on underwhelming neoantigen vaccine data
seekingalpha.com - July 30 at 2:29 PM
Genocea Biosciences (NASDAQ:GNCA) Price Target Lowered to $7.00 at Needham & Company LLCGenocea Biosciences (NASDAQ:GNCA) Price Target Lowered to $7.00 at Needham & Company LLC
www.americanbankingnews.com - July 30 at 2:15 PM
Genocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint InhibitorsGenocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint Inhibitors
finance.yahoo.com - July 30 at 9:28 AM
Genocea Biosciences (NASDAQ:GNCA) Shares Gap Down to $5.02Genocea Biosciences (NASDAQ:GNCA) Shares Gap Down to $5.02
www.americanbankingnews.com - July 29 at 2:39 PM
Genocea Biosciences Inc (NASDAQ:GNCA) Major Shareholder Buys $7,090,335.00 in StockGenocea Biosciences Inc (NASDAQ:GNCA) Major Shareholder Buys $7,090,335.00 in Stock
www.americanbankingnews.com - July 28 at 10:08 PM
Genocea Biosciences (NASDAQ:GNCA)  Shares Down 9.2% Genocea Biosciences (NASDAQ:GNCA) Shares Down 9.2%
www.americanbankingnews.com - July 28 at 9:01 PM
Genocea Biosciences (NASDAQ:GNCA) Trading 11.6% Higher Genocea Biosciences (NASDAQ:GNCA) Trading 11.6% Higher
www.americanbankingnews.com - July 27 at 1:48 PM
Genocea Biosciences Sees Unusually High Options Volume (NASDAQ:GNCA)Genocea Biosciences Sees Unusually High Options Volume (NASDAQ:GNCA)
www.americanbankingnews.com - July 27 at 1:14 PM
Genocea Biosciences (NASDAQ:GNCA) Releases Quarterly  Earnings Results, Beats Expectations By $0.01 EPSGenocea Biosciences (NASDAQ:GNCA) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - July 24 at 10:21 AM
Genocea Biosciences (NASDAQ:GNCA) Shares Gap Up to $3.14Genocea Biosciences (NASDAQ:GNCA) Shares Gap Up to $3.14
www.americanbankingnews.com - July 23 at 9:36 PM
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2020 Results - Earnings Call TranscriptGenocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - July 23 at 12:28 PM
Genocea Biosciences (NASDAQ:GNCA) Earns "Buy" Rating from HC WainwrightGenocea Biosciences (NASDAQ:GNCA) Earns "Buy" Rating from HC Wainwright
www.americanbankingnews.com - July 23 at 11:39 AM
Genocea Provides Second Quarter 2020 Corporate UpdateGenocea Provides Second Quarter 2020 Corporate Update
finance.yahoo.com - July 23 at 7:28 AM
Genocea secures equity capital of $80MGenocea secures equity capital of $80M
seekingalpha.com - July 22 at 10:41 AM
Genocea Announces Private Placement Financing of Up to $80 MillionGenocea Announces Private Placement Financing of Up to $80 Million
finance.yahoo.com - July 22 at 10:41 AM
Genocea Biosciences (NASDAQ:GNCA) Rating Reiterated by Needham & Company LLCGenocea Biosciences (NASDAQ:GNCA) Rating Reiterated by Needham & Company LLC
www.americanbankingnews.com - July 21 at 6:53 AM
Genocea Biosciences provides clinical update for GEN-009 and GEN-011Genocea Biosciences provides clinical update for GEN-009 and GEN-011
seekingalpha.com - July 20 at 3:03 PM
Genocea Biosciences (NASDAQ:GNCA) Shares Up 3.8%Genocea Biosciences (NASDAQ:GNCA) Shares Up 3.8%
www.americanbankingnews.com - July 20 at 1:42 PM
Genocea Biosciences Provides Clinical UpdateGenocea Biosciences Provides Clinical Update
finance.yahoo.com - July 20 at 10:02 AM
Genocea Biosciences (GNCA) Set to Announce Quarterly Earnings on ThursdayGenocea Biosciences (GNCA) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - July 17 at 9:52 AM
Genocea to Host Second Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - July 16 at 9:59 AM
Genocea to Host Second Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - July 16 at 9:59 AM
Zacks: Brokerages Anticipate Genocea Biosciences Inc (NASDAQ:GNCA) to Post -$0.41 Earnings Per ShareZacks: Brokerages Anticipate Genocea Biosciences Inc (NASDAQ:GNCA) to Post -$0.41 Earnings Per Share
www.americanbankingnews.com - July 13 at 5:31 AM
Genocea to Present Data that Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology at AACR Virtual Annual Meeting IIGenocea to Present Data that Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology at AACR Virtual Annual Meeting II
finance.yahoo.com - June 22 at 10:15 AM
Genocea Files IND Application for GEN-011, a T cell Therapy Designed to Improve on Current Limitations of TIL TherapyGenocea Files IND Application for GEN-011, a T cell Therapy Designed to Improve on Current Limitations of TIL Therapy
finance.yahoo.com - June 15 at 8:25 AM
Hedge Funds Not Interested In Infinity Pharmaceuticals Inc. (INFI) AnymoreHedge Funds Not Interested In Infinity Pharmaceuticals Inc. (INFI) Anymore
finance.yahoo.com - June 10 at 5:11 PM
Genocea Presents Updated Long-term Safety, Immunogenicity and Durability Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial Part A at Virtual ASCO 2020Genocea Presents Updated Long-term Safety, Immunogenicity and Durability Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial Part A at Virtual ASCO 2020
finance.yahoo.com - May 29 at 12:27 PM
Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 AntigensGenocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens
finance.yahoo.com - May 19 at 7:41 AM
Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020
finance.yahoo.com - May 13 at 6:17 PM
Genocea Introduces GEN-011, a Transformational T cell Therapy Designed to Improve on Current Limitations of TIL TherapyGenocea Introduces GEN-011, a Transformational T cell Therapy Designed to Improve on Current Limitations of TIL Therapy
finance.yahoo.com - May 12 at 10:11 PM
REMINDER: Genocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid TumorsREMINDER: Genocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors
finance.yahoo.com - May 11 at 10:05 PM
REMINDER: Genocea to Host KOL Symposium Highlighting GEN-011s Potential to Transform T cell Therapy for Solid TumorsREMINDER: Genocea to Host KOL Symposium Highlighting GEN-011's Potential to Transform T cell Therapy for Solid Tumors
www.benzinga.com - May 11 at 5:04 PM
Edited Transcript of GNCA earnings conference call or presentation 30-Apr-20 12:30pm GMTEdited Transcript of GNCA earnings conference call or presentation 30-Apr-20 12:30pm GMT
finance.yahoo.com - May 11 at 5:04 PM
Genocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid TumorsGenocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors
finance.yahoo.com - May 5 at 5:47 PM
Genocea Provides First Quarter 2020 Corporate UpdateGenocea Provides First Quarter 2020 Corporate Update
www.benzinga.com - April 30 at 4:32 PM
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2020 Results - Earnings Call TranscriptGenocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - April 30 at 4:32 PM
Genocea to Host First Quarter 2020 Corporate Update Conference Call & WebcastGenocea to Host First Quarter 2020 Corporate Update Conference Call & Webcast
finance.yahoo.com - April 23 at 11:07 PM
Genocea Biosciences, Inc. (GNCA) Shares March Higher, Can It Continue?Genocea Biosciences, Inc. (GNCA) Shares March Higher, Can It Continue?
finance.yahoo.com - April 23 at 1:06 PM
Genocea to Present Virtually at the 19th Annual Needham Healthcare ConferenceGenocea to Present Virtually at the 19th Annual Needham Healthcare Conference
finance.yahoo.com - April 8 at 7:47 PM
Genocea Biosciences (GNCA) - Options ChainGenocea Biosciences (GNCA) - Options Chain
www.fool.com - March 24 at 11:19 PM
Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His LifeRealtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life
www.marketwatch.com - March 2 at 9:19 AM
Genocea to Present at the Cowen & Company 40th Annual Health Care ConferenceGenocea to Present at the Cowen & Company 40th Annual Health Care Conference
finance.yahoo.com - February 26 at 7:37 PM
Genocea to Present at the SVB Leerink 9th Annual Global Healthcare ConferenceGenocea to Present at the SVB Leerink 9th Annual Global Healthcare Conference
finance.yahoo.com - February 20 at 3:10 PM
Edited Transcript of GNCA earnings conference call or presentation 13-Feb-20 1:30pm GMTEdited Transcript of GNCA earnings conference call or presentation 13-Feb-20 1:30pm GMT
finance.yahoo.com - February 18 at 9:18 AM
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q4 2019 Results - Earnings Call TranscriptGenocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 13 at 3:50 PM
Genocea Provides Fourth Quarter 2019 Corporate UpdateGenocea Provides Fourth Quarter 2019 Corporate Update
finance.yahoo.com - February 13 at 10:50 AM
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.